BR0112497A - Antìgenos de streptococcus pyogenes - Google Patents

Antìgenos de streptococcus pyogenes

Info

Publication number
BR0112497A
BR0112497A BR0112497-8A BR0112497A BR0112497A BR 0112497 A BR0112497 A BR 0112497A BR 0112497 A BR0112497 A BR 0112497A BR 0112497 A BR0112497 A BR 0112497A
Authority
BR
Brazil
Prior art keywords
streptococcus pyogenes
antigens
pyogenes antigens
streptococcus
prophylaxis
Prior art date
Application number
BR0112497-8A
Other languages
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard R Brodeur
Stephane Rioux
Martine Boyer
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of BR0112497A publication Critical patent/BR0112497A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"ANTìGENOS DE STREPTOCOCCUS PYOGENES". A presente invenção se refere a antígenos, mais particularmente um antígeno de patógeno bacteriano de Streptococcus pyogenes (também chamado de streptococcus de grupo (GAS) ) que é útil como componente de vacina para a terapia e/ou a profilaxia.
BR0112497-8A 2000-07-06 2001-07-06 Antìgenos de streptococcus pyogenes BR0112497A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06
PCT/CA2001/001001 WO2002004495A2 (en) 2000-07-06 2001-07-06 Streptococcus pyogenes antigen

Publications (1)

Publication Number Publication Date
BR0112497A true BR0112497A (pt) 2003-11-25

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112497-8A BR0112497A (pt) 2000-07-06 2001-07-06 Antìgenos de streptococcus pyogenes

Country Status (10)

Country Link
US (2) US7247308B2 (pt)
EP (1) EP1297145B1 (pt)
JP (1) JP4718099B2 (pt)
AT (1) ATE412750T1 (pt)
AU (1) AU7227001A (pt)
BR (1) BR0112497A (pt)
CA (1) CA2413576C (pt)
DE (1) DE60136360D1 (pt)
ES (1) ES2316458T3 (pt)
WO (1) WO2002004495A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4718099B2 (ja) 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
CA2432525C (en) * 2000-12-21 2012-11-27 Shire Biochem Inc. Streptococcus pyogenes antigens and corresponding dna fragments
EP1597348A4 (en) * 2002-08-26 2010-03-31 Novartis Vaccines & Diagnostic GENES OF STREPTOCOCCUS PRESERVED OR SPECIFIC
PL1648500T3 (pl) * 2003-07-31 2014-12-31 Novartis Vaccines & Diagnostics Inc Kompozycje immunogenne dla Streptococcus pyogenes
EP1660660B1 (en) * 2003-08-15 2013-07-24 ID Biomedical Corporation of Quebec Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20090317420A1 (en) * 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
JP2008544949A (ja) * 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
US20110206692A1 (en) * 2006-06-09 2011-08-25 Novartis Ag Conformers of bacterial adhesins
JP2010508276A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 化膿連鎖球菌のための免疫原性組成物および治療組成物
RU2471497C2 (ru) 2007-09-12 2013-01-10 Новартис Аг Мутантные антигены gas57 и антитела против gas57
CN104292312A (zh) 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式
KR102033185B1 (ko) 2011-06-17 2019-10-16 유니버시티 오브 테네시 리서치 파운데이션 그룹 a 스트렙토콕쿠스 다가 백신
US9650425B2 (en) 2013-02-11 2017-05-16 University Of Tennessee Research Foundation Group A streptococcal M-related proteins and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (en) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
JP4718099B2 (ja) 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原

Also Published As

Publication number Publication date
WO2002004495A3 (en) 2002-06-13
DE60136360D1 (de) 2008-12-11
WO2002004495A2 (en) 2002-01-17
CA2413576A1 (en) 2002-01-17
ES2316458T3 (es) 2009-04-16
JP4718099B2 (ja) 2011-07-06
CA2413576C (en) 2012-11-13
US20080038268A1 (en) 2008-02-14
US7247308B2 (en) 2007-07-24
US7811585B2 (en) 2010-10-12
ATE412750T1 (de) 2008-11-15
JP2004502446A (ja) 2004-01-29
US20030165528A1 (en) 2003-09-04
EP1297145B1 (en) 2008-10-29
AU7227001A (en) 2002-01-21
EP1297145A2 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
BR0112497A (pt) Antìgenos de streptococcus pyogenes
BE2021C506I2 (pt)
ATE227134T1 (de) Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
BR0114786A (pt) Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição
ATE542829T1 (de) Impfstoff
AU2001278003A1 (en) Bacteriophage having multiple host range
BRPI0408085A (pt) composição e método para o tratamento e prevenção de infecções entéricas bacterianas
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
BRPI0416205A (pt) uso de antibióticos como adjuvantes de vacina
EA201001479A1 (ru) Вакцина
BRPI0113155C1 (pt) métodos para produção de uma vacina para hepatite b e de um antígeno de superfície para hepatite b
WO2022159685A3 (en) Sars-cov-2 coronavirus antibodies and uses thereof
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
BRPI0512921A (pt) processo para tratamento e profilaxia de ms
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
DE69835424D1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
EP1379556A4 (en) ANTI-PILYROSPORUM OVAL LGY AND ITS USE
BR0114403A (pt) Polipeptìdeos de "haemophilus influenzae" que podem ser usados para fins de profilaxia, diagnóstico e/ou terapia
DK0894500T3 (da) Streptococcus equi-vaccine
BR0210875A (pt) Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes
WO2023150682A3 (en) Pan-coronavirus immunogenic compositions
BR0303500A (pt) Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo
WO2024177525A3 (en) An epitope originating from sars-cov-2 n protein, an antigen containing the epitope, uses thereof and a method for detecting disease caused by coronavirus

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SHIRE BIOCHEM INC. (CA)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDA ATRAVES DA PETICAO NO 0200500112577/RJ DE 11/10/2005.

B25A Requested transfer of rights approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: TRANSFERIDO DE: SHIRE BIOCHEM INC.

B25G Requested change of headquarter approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018070070670/SP DE 24/10/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2313 DE 05-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.